John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer at Rocket Pharmaceuticals (NASDAQ:RCKT), sold shares of the company's common stock on May 13, 2026.
The transaction involved the sale of 855 shares, totaling $3,083. The shares were sold at a price of $3.606 per share. This sale was conducted to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
The stock currently trades at $3.40, down roughly 52% from its 52-week high of $7.14, though shares have gained about 3% year-to-date.
Following this transaction, Mr. Militello directly holds 90,164 shares. According to Bond.az analysis, RCKT appears undervalued at current levels. The company holds more cash than debt on its balance sheet, though it is quickly burning through cash.
The transaction was reported in a Form 4 filing with the Securities and Exchange Commission on May 14, 2026.
